109 related articles for article (PubMed ID: 7981068)
1. How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
Fosså SD; Jacobsen AB; Aass N; Heilo A; Stenwig AE; Kummen O; Johannessen NB; Waaler G; Ogreid P; Borge L
Br J Cancer; 1994 Dec; 70(6):1156-60. PubMed ID: 7981068
[TBL] [Abstract][Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?
Harvey ML; Geldart TR; Duell R; Mead GM; Tung K
Ann Oncol; 2002 Feb; 13(2):237-42. PubMed ID: 11886000
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Guney S; Guney N; Sonmez NC; Ergenekon E
Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Kausitz J; Ondrus D; Belan V; Matoska J
Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
[TBL] [Abstract][Full Text] [Related]
6. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
7. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.
Rørth M; Jacobsen GK; von der Maase H; Madsen EL; Nielsen OS; Pedersen M; Schultz H
J Clin Oncol; 1991 Sep; 9(9):1543-8. PubMed ID: 1714948
[TBL] [Abstract][Full Text] [Related]
8. [Use of prognostic factors of disease progression in the treatment of patients with stage I nonseminomatous testicular tumors].
Ondrus D
Bratisl Lek Listy; 1999 Jan; 100(1):61-5. PubMed ID: 10493000
[TBL] [Abstract][Full Text] [Related]
9. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
10. Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
Iwatsuki S; Naiki T; Kawai N; Etani T; Iida K; Ando R; Nagai T; Okada A; Tozawa K; Sugiyama Y; Yasui T
J Med Case Rep; 2016 May; 10(1):114. PubMed ID: 27150447
[TBL] [Abstract][Full Text] [Related]
11. Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy.
Janowitz T; Welsh S; Warren AY; Robson J; Thomas B; Shaw A; Ainsworth NL; Neal DE; Mazhar D
BMC Res Notes; 2015 Oct; 8():524. PubMed ID: 26428307
[TBL] [Abstract][Full Text] [Related]
12. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
13. [A CASE OF ADVANCED NON-SEMINOMATOUS TESTICULAR GERM CELL TUMOR ACCOMPANIED PANIC DISORDER].
Okumura A; Morii A; Kiriyama M; Takamatsu H; Shimizu M; Yasui S; Takagawa K
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):48-53. PubMed ID: 28132992
[TBL] [Abstract][Full Text] [Related]
14. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
15. [Position of surveillance therapy in clinical stage I testicular non-seminoma].
Thon WF; Sparwasser C; Gilbert P; Altwein JE
Urol Int; 1987; 42(6):445-9. PubMed ID: 2834854
[TBL] [Abstract][Full Text] [Related]
16. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance.
Ondrusova M; Suchansky M; Psota M; Zeleny T; Ondrus D
Bratisl Lek Listy; 2018; 119(1):3-5. PubMed ID: 29405722
[TBL] [Abstract][Full Text] [Related]
17. Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance.
Hao D; Seidel J; Brant R; Alexander F; Ernst DS; Summers N; Russell JA; Stewart DA
J Urol; 1998 Sep; 160(3 Pt 1):768-71. PubMed ID: 9720544
[TBL] [Abstract][Full Text] [Related]
18. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
19. Reliability of diagnostic imaging after orchiectomy alone in follow-up of clinical stage I testicular carcinoma: excessive cost with potential risk.
Tesoro-Tess JD; Pizzocaro G; Zanoni F; Balzarini L; Ceglia E; Petrillo R; Musumeci R
Lymphology; 1987 Sep; 20(3):161-5. PubMed ID: 3682940
[TBL] [Abstract][Full Text] [Related]
20. ["Surveillance" of non-seminomatous testicular tumors. A prospective study of 100 patients in the first stage of illness].
Hornák M; Zvara V; Ondrus D
Ann Urol (Paris); 1992; 26(5):306-10. PubMed ID: 1485800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
